Montauk Renewables (MNTK) Q2 2025 earnings summary

Executive summary

• Q2 2025 revenues increased 4.1% year-over-year to $45.1 million, driven by higher RNG segment revenues and timing of RIN sales, despite lower realized RIN prices and regulatory impacts.

• Net loss widened to $5.5 million from $0.7 million in Q2 2024, reflecting higher operating expenses, increased impairment losses, and lower RIN pricing.

• Major capital projects advanced, including commissioning of the Second Apex RNG Facility and ongoing investments in Montauk Ag Renewables, Bowerman, and Tulsa projects.

• RNG production was flat at 1.4 million MMBtu, while renewable electricity output declined 6.7% year-over-year.

• Regulatory changes, including EPA RFS waivers and BRRR implementation, affected RIN timing, pricing, and inventory.

Financial highlights

• Q2 2025 total revenues: $45.1 million (+4.1% YoY); RNG segment revenues: $40.8 million (+5.1% YoY); renewable electricity revenues: $4.3 million (-4.5% YoY).

• Net loss: $5.5 million (vs. $0.7 million loss in Q2 2024); six-month net loss: $6.0 million (vs. $1.1 million net income prior year).

• Adjusted EBITDA for Q2 2025: $5.0 million (down 28.6% YoY); six-month Adjusted EBITDA: $13.8 million (down from $16.4 million).

• Operating loss: $2.4 million (vs. $0.9 million operating income in Q2 2024); gross margin compressed due to higher O&M and lower RIN prices.

• Cash and equivalents at June 30, 2025: $29.1 million; capital expenditures for H1 2025: $45.3 million.

Outlook and guidance

• Full-year 2025 RNG production guidance: 5.8–6.0 million MMBtu; RNG revenues: $150–$170 million.

• Renewable electricity production expected at 178,000–186,000 MWh; revenues $17–$18 million.

• Montauk Ag Renewables project targets 2026 for commercial operations; Tulsa and Rumpke projects expected in 2027–2028.

• 50–75% of project capital may qualify for investment tax credits under new legislation.

• Guidance reaffirmed despite regulatory uncertainty and market volatility.